Clinical Trial Update: CLAD Deconvolved PERG Responses in Glaucoma Patients [NA]

View source ↗

Summary

A recruiting clinical trial sponsored by Jorvec Corp is investigating CLAD deconvolved PERG responses in patients with glaucoma or glaucoma suspect.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Glaucoma Suspect

Snippet

Sponsor: Jorvec Corp. | Conditions: Glaucoma, Suspect | NA | Status: RECRUITING